Pay in 4 interest-free payments of $5.93 Learn more
Ships within 48 hours · Estimated delivery Oct 27 - Nov 1
The rationale for combining the two is pharmacological complementarity
NYHA, New York Heart Association Classification
156,157 Drugs targeting cardiac Gln metabolism are being developed
A more complex decision landscape revealed in erythrocytes might shift the equilibrium in the discussion of perception of mature erythrocytes as living or non-living entities [4] in the direction of the former
Most patients return to normal activities during the process
US$ 24.94
US$ 28.20
US$ 24.27
US$ 27.76
US$ 23.18
US$ 28.39
US$ 21.28
